Status:
NOT_YET_RECRUITING
Caffeine Optimization for Oxygen Saturation Index in ELBW Infants
Lead Sponsor:
University of Rochester
Conditions:
Neonatal Apnea
Infants
Eligibility:
All Genders
Up to 27 years
Phase:
PHASE2
Brief Summary
The goal of this clinical trial is to determine whether a higher dose of caffeine citrate can improve breathing and reduce health complications in extremely premature infants, specifically those born ...
Eligibility Criteria
Inclusion
- URMC Inborn Newborn infants born with gestational age of 22 weeks 0 days - 27 weeks 6 days or infants OR ≥ 28 weeks with a birthweight \< 1000 grams
Exclusion
- Hepatic failure, spontaneous intestinal perforation, necrotizing enterocolitis, Anticipated major congenital or genetic anomalies, infants not anticipated to survive beyond 72 hours, infants with mothers that are non-English speaking or \<18 years old at time of enrollment.
Key Trial Info
Start Date :
November 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2027
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT07216365
Start Date
November 1 2025
End Date
September 1 2027
Last Update
October 14 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.